Anti-Mllerian Hormone (AMH) is a glycoprotein hormone produced by granulosa cells in ovarian follicles. Its levels in a woman’s blood are often used as an indicator of ovarian reserve, which is the number of remaining eggs. Strategies to elevate AMH levels are a subject of interest for individuals seeking to improve fertility outcomes. For example, women undergoing in-vitro fertilization (IVF) may explore methods believed to influence AMH concentrations.
The significance of AMH lies in its correlation with reproductive potential, particularly as ovarian reserve naturally declines with age. Higher AMH levels generally indicate a greater number of viable eggs. Historically, interventions aimed at manipulating AMH have been met with varying degrees of success, highlighting the complexity of ovarian physiology and the limitations of current medical technologies.
